Skip to content

Effects of Repetitive Transcranial Magnetic Stimulation Combined with Cognitive Stimulation Therapy on Cognitive Function, Psychological and Behavioral Symptoms, and Quality of Life in Patients with Alzheimer's Disease

Effects of Repetitive Transcranial Magnetic Stimulation Combined with Cognitive Stimulation Therapy on Cognitive Function, Psychological and Behavioral Symptoms, and Quality of Life in Patients with Alzheimer's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123176
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s Disease(AD)

Interventions

control group:Repetitive transcranial magnetic stimulation (rTMS)+ routine activities
Intervention group: repetitive transcranial magneticstimulation, rTMS + Cognitive Stimulation Therapy,CST

Sponsors

The Affiliated Brain Hospital , Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for moderate to severe neurocognitive impairment as outlined in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5); 2. Aged 60 or above; 3. Score of 10 to 24 on the Mini-Mental State Examination (MMSE); 4. Clinical Dementia Rating Scale (CDR) score = 2 (and = 0.5); 5. Taking anti-dementia drugs (cholinesterase inhibitors and memantine) and antipsychotic drugs (quetiapine, olanzapine, or risperidone); 6. The patient possesses a certain degree of language comprehension and communication ability; 7. Have good vision and hearing, and be able to use most of the materials used in treatment; 8. The patient and/or their family members sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Exclude major physical illnesses such as pneumonia, malnutrition, severe cardiovascular disease, etc; 2. Exclude serious behavioral symptoms, such as speaking loudly or continuously, wandering, shouting, attacking, etc; 3. Exclude dementia caused by other diseases, such as vascular dementia, frontotemporal dementia, Lewy body dementia, etc; 4. Exclude patients with pseudodementia caused by depression (Hamilton Depression Scale score = 17); 5. Exclude patients with a history of mental illness (such as schizophrenia);

Design outcomes

Primary

MeasureTime frame
cognitive function;behavioral and psychological symptoms;

Secondary

MeasureTime frame
Quality of Live;

Countries

China

Contacts

Public ContactBo Li

The Affiliated Brain Hospital , Guangzhou Medical University

lbmmc@163.com+86 20 8126 8015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026